Annual Cash & Cash Equivalents
$77.91 M
+$2.98 M+3.97%
December 31, 2023
Summary
- As of February 12, 2025, VSTM annual cash & cash equivalents is $77.91 million, with the most recent change of +$2.98 million (+3.97%) on December 31, 2023.
- During the last 3 years, VSTM annual cash & cash equivalents has risen by +$10.13 million (+14.94%).
- VSTM annual cash & cash equivalents is now -40.01% below its all-time high of $129.87 million, reached on December 31, 2018.
Performance
VSTM Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$113.17 M
+$29.80 M+35.75%
September 30, 2024
Summary
- As of February 12, 2025, VSTM quarterly cash and cash equivalents is $113.17 million, with the most recent change of +$29.80 million (+35.75%) on September 30, 2024.
- Over the past year, VSTM quarterly cash and cash equivalents has increased by +$35.27 million (+45.27%).
- VSTM quarterly cash and cash equivalents is now -38.18% below its all-time high of $183.09 million, reached on June 30, 2023.
Performance
VSTM Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
VSTM Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +4.0% | +45.3% |
| 3 y3 years | +14.9% | +51.0% |
| 5 y5 years | -40.0% | +51.0% |
VSTM Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +266.6% | -38.2% | +432.5% |
| 5 y | 5-year | at high | +266.6% | -38.2% | +432.5% |
| alltime | all time | -40.0% | +671.7% | -38.2% | +1021.0% |
Verastem Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $113.17 M(+35.7%) |
| Jun 2024 | - | $83.37 M(+2.5%) |
| Mar 2024 | - | $81.32 M(+4.4%) |
| Dec 2023 | $77.91 M(+4.0%) | $77.91 M(-18.0%) |
| Sep 2023 | - | $94.99 M(-48.1%) |
| Jun 2023 | - | $183.09 M(+88.2%) |
| Mar 2023 | - | $97.26 M(+29.8%) |
| Dec 2022 | $74.93 M(+252.6%) | $74.93 M(-4.1%) |
| Sep 2022 | - | $78.17 M(+22.2%) |
| Jun 2022 | - | $63.95 M(+37.0%) |
| Mar 2022 | - | $46.69 M(+119.7%) |
| Dec 2021 | $21.25 M(-68.6%) | $21.25 M(-12.6%) |
| Sep 2021 | - | $24.31 M(-2.6%) |
| Jun 2021 | - | $24.97 M(-29.7%) |
| Mar 2021 | - | $35.51 M(-47.6%) |
| Dec 2020 | $67.78 M(+55.8%) | $67.78 M(-60.2%) |
| Sep 2020 | - | $170.47 M(+36.0%) |
| Jun 2020 | - | $125.33 M(-7.2%) |
| Mar 2020 | - | $135.06 M(+210.4%) |
| Dec 2019 | $43.51 M(-66.5%) | $43.51 M(-57.9%) |
| Sep 2019 | - | $103.32 M(-8.6%) |
| Jun 2019 | - | $113.08 M(+23.6%) |
| Mar 2019 | - | $91.53 M(-29.5%) |
| Dec 2018 | $129.87 M | $129.87 M(-0.7%) |
| Sep 2018 | - | $130.73 M(-22.5%) |
| Jun 2018 | - | $168.69 M(+162.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2018 | - | $64.22 M(-21.9%) |
| Dec 2017 | $82.18 M(+154.0%) | $82.18 M(+60.3%) |
| Sep 2017 | - | $51.27 M(+85.9%) |
| Jun 2017 | - | $27.58 M(-2.1%) |
| Mar 2017 | - | $28.18 M(-12.9%) |
| Dec 2016 | $32.35 M(+30.1%) | $32.35 M(-13.2%) |
| Sep 2016 | - | $37.27 M(-5.8%) |
| Jun 2016 | - | $39.56 M(+161.2%) |
| Mar 2016 | - | $15.15 M(-39.1%) |
| Dec 2015 | $24.87 M(-26.6%) | $24.87 M(+25.4%) |
| Sep 2015 | - | $19.83 M(-43.6%) |
| Jun 2015 | - | $35.17 M(+16.8%) |
| Mar 2015 | - | $30.13 M(-11.1%) |
| Dec 2014 | $33.90 M(+79.5%) | $33.90 M(+64.9%) |
| Sep 2014 | - | $20.56 M(-8.2%) |
| Jun 2014 | - | $22.39 M(+69.1%) |
| Mar 2014 | - | $13.24 M(-29.9%) |
| Dec 2013 | $18.89 M(+87.1%) | $18.89 M(-16.6%) |
| Sep 2013 | - | $22.64 M(+63.1%) |
| Jun 2013 | - | $13.88 M(-50.9%) |
| Mar 2013 | - | $28.25 M(+179.8%) |
| Dec 2012 | $10.10 M(-51.8%) | $10.10 M(-9.3%) |
| Sep 2012 | - | $11.13 M(-29.4%) |
| Jun 2012 | - | $15.75 M(-38.2%) |
| Mar 2012 | - | $25.47 M(+21.6%) |
| Dec 2011 | $20.95 M | $20.95 M(-66.1%) |
| Sep 2011 | - | $61.82 M |
FAQ
- What is Verastem annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Verastem?
- What is Verastem annual cash & cash equivalents year-on-year change?
- What is Verastem quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Verastem?
- What is Verastem quarterly cash and cash equivalents year-on-year change?
What is Verastem annual cash & cash equivalents?
The current annual cash & cash equivalents of VSTM is $77.91 M
What is the all time high annual cash & cash equivalents for Verastem?
Verastem all-time high annual cash & cash equivalents is $129.87 M
What is Verastem annual cash & cash equivalents year-on-year change?
Over the past year, VSTM annual cash & cash equivalents has changed by +$2.98 M (+3.97%)
What is Verastem quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of VSTM is $113.17 M
What is the all time high quarterly cash and cash equivalents for Verastem?
Verastem all-time high quarterly cash and cash equivalents is $183.09 M
What is Verastem quarterly cash and cash equivalents year-on-year change?
Over the past year, VSTM quarterly cash and cash equivalents has changed by +$35.27 M (+45.27%)